IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$6.27M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
74
New
Increased
Reduced
Closed

Top Buys

1
+$4.85M
2
+$4.33M
3
+$4.09M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$4.04M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.88M

Top Sells

1
+$7.11M
2
+$5.43M
3
+$5.4M
4
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
+$5.01M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.63M

Sector Composition

1 Healthcare 91.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$3.04M 1.18%
247,500
-73,244
27
$2.95M 1.15%
9,400
-2,800
28
$2.92M 1.14%
108,000
-21,000
29
$2.82M 1.1%
+63,000
30
$2.8M 1.09%
971,922
+199,922
31
$2.75M 1.07%
+1,544
32
$2.61M 1.02%
51,500
33
$2.15M 0.84%
322,436
34
$2.03M 0.79%
182,930
-270,070
35
$1.69M 0.66%
+1,256
36
$1.64M 0.64%
+17,000
37
$1.6M 0.62%
+83,000
38
$1.49M 0.58%
170,000
39
$1.33M 0.52%
20,000
-17,000
40
$1.32M 0.51%
61,000
+30,761
41
$1.3M 0.5%
24,000
-52,000
42
$1.27M 0.49%
68,391
43
$1.19M 0.46%
74,538
-80,000
44
$1.07M 0.42%
+12,000
45
$1.06M 0.41%
16,996
46
$971K 0.38%
+39,000
47
$930K 0.36%
70,446
48
$883K 0.34%
+58,600
49
$876K 0.34%
69,000
-100,000
50
$838K 0.33%
20,953
1
2
3